Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine

Journal of the American Aging Association

Volumn 23, Issue 1, 2000, Pages 33-40

  Georgescu, A ^a   Popov, D ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; GLYCATION; HYPERGLYCEMIA; HYPERLIPIDEMIA; LENS; NONHUMAN; PROTEIN ANALYSIS;

EID: 0033830001     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-000-0005-x     Document Type: Article

References (48)

1. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs)
2. Nonenzymatic browning in vivo: Possible process for aging of long lived proteins
3. Advanced glycosylation end products: A new disease marker for diabetes and aging
4. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen
5. Glycation of human lens proteins: Preferential glycation of αA subunits
6. Review of diabetes: Identification of markers for early detection, glycemic control, and monitoring clinical complications
7. Advanced glycosylated endproducts: Role in diabetic and non-diabetic vascular disease
8. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
9. The advanced glycation end-product N(ε) - (carboxymethyl) - lysine, is a product of both lipid peroxidation and glycoxidation reactions
10. Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus
11. The assessment of protein glycation in human atherosclerotic plaques by affinity chromatography
12. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions
13. A fluorescence plate reader assay for monitoring the susceptibility of biological samples to lipid peroxidation
14. The hyperlipidemic hamster as a model of experimental atherosclerosis
15. The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemia
16. Pathobiochemistry of combined diabetes and atherosclerosis studied on a novel animal model
17. Lipoprotein metabolism in diabetes mellitus
18. Advanced glycosylation end products in the mesenteric artery
19. Vascular hypertrophy in experimental diabetes - Role of advanced glycation end products
20. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition
21. Immunochemical detection of advanced glycation end products in lens crystallins from streptozotocin-induced diabetic rat
22. Relationship between lens protein glycation and membrane structure in human cataract
23. Glycation of human ens proteins from diabetic and (nondiabetic) senile cataract patients
24. L-Arginine reduces glomerular basement membrane collagen N(ε)-carboxymethyllysine in the diabetic db/db mouse
25. Age-related fluorescence in rat lung collagen
26. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats
27. Post-translational non-enzymatic modification of proteins. II. Separation of selected protein species after glycation and other carbonyl-mediated modifications
28. Specific fluorescence assay for advanced glycation endproducts in blood and urine of diabetic patients
29. Relationship between auto-fluorescence and advanced glycation endproducts in diabetic lenses
30. Advanced glycated end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds
31. Lens autofluorescence is increased in newly diagnosed patients with NIDDM
32. Glycation of collagen in hypertriglyceridemic rats
33. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
34. Evidence for a link between glycoxidation and lipoperoxidation in patients with chronic renal failure
35. Nichtenzymatische glykierung und oxidativer stress bei chronischen Erkrankungen und diabetes mellitus
36. The relative UV sensitizer activity of purified advanced glycation endproducts
37. Mutual interaction between glycation and oxidation during non-enzymatic protein modification
38. The use of the myograph technique for the investigation of the vascular reactivity. A review
39. Role of the Maillard reaction in aging of tissue proteins - Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins
40. Insulin secretion from pancreatic β cells caused by L-arginine-derived nitrogen oxides
41. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine in endothelial dysfunction
42. Reactive oxygen species-induced impairment of endothelium-dependent relaxation in rat aortic rings: Protection by L-arginine
43. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after baloon angioplasty
44. Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
45. Cholesterol oxides accumulate in human cataracts
46. Cholesterol may act as an antioxidant in lens membranes
47. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding